| P2093 | author name string | John A. Heit | |
| P2860 | cites work | Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer | Q28186303 |
| | Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study | Q33601589 |
| | The epidemiology of venous thromboembolism in the community | Q33865646 |
| | Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study | Q33895888 |
| | Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials | Q33910755 |
| | Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis | Q33972711 |
| | Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism | Q34144428 |
| | Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review | Q34145656 |
| | Risk assessment for recurrent venous thrombosis | Q34153343 |
| | Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism | Q34179254 |
| | Thrombophilia, clinical factors, and recurrent venous thrombotic events | Q34419598 |
| | Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis | Q34603112 |
| | The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism | Q35291820 |
| | Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study | Q35525678 |
| | Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study | Q35642537 |
| | Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial | Q35724847 |
| | Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology | Q35813336 |
| | Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review | Q36445071 |
| | Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. | Q36550717 |
| | Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study | Q37389225 |
| | Venous thromboembolism: risk factors for recurrence | Q37396634 |
| | Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies | Q37829868 |
| | Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review | Q37849816 |
| | Recurrent venous thromboembolism after surgery-provoked versus unprovoked thromboembolism | Q38446402 |
| | Risks of oral anticoagulant therapy with increasing age. | Q40406454 |
| | Recurrence of venous thromboembolism in patients with familial thrombophilia | Q41620452 |
| | Major bleeding after hospitalization for deep-venous thrombosis. | Q41703407 |
| | No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study | Q42165716 |
| | Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism | Q43556960 |
| | Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. | Q43597590 |
| | Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients | Q43611776 |
| | Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators | Q43681404 |
| | The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders | Q43889366 |
| | Extended oral anticoagulant therapy after a first episode of pulmonary embolism. | Q44496670 |
| | Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism | Q44548746 |
| | Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. | Q45940952 |
| | Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. | Q46470692 |
| | Major bleeding complications in a specialized anticoagulation service | Q46648532 |
| | The risk of recurrent venous thromboembolism in men and women | Q47332296 |
| | The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis | Q47849081 |
| | Venous thromboembolism hospitalizations among American Indians and Alaska Natives | Q47993392 |
| | High plasma levels of factor VIII and risk of recurrence of venous thromboembolism | Q48036239 |
| | Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis | Q49168732 |
| | A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism | Q49171054 |
| | Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. | Q50633316 |
| | Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. | Q50780747 |
| | Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. | Q51008134 |
| | Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. | Q51603817 |
| | Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. | Q51831890 |
| | Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model. | Q52006467 |
| | Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences. | Q53317158 |
| | Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. | Q53333711 |
| | Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. | Q53354829 |
| | The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. | Q53361537 |
| | A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. | Q53374794 |
| | Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study | Q56989286 |
| | Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal | Q56997786 |
| | D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis | Q56999261 |
| | Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism | Q57317313 |
| | The Long-Term Clinical Course of Acute Deep Venous Thrombosis | Q64386235 |
| | Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy | Q69742234 |
| | Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota | Q71944908 |
| | Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy | Q73286594 |
| | Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors | Q73592975 |
| | The risk of recurrent venous thromboembolism among patients with high factor IX levels | Q73691028 |
| | Recurrent venous thrombosis and markers of inflammation | Q73710368 |
| | Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study | Q73836575 |
| | D-dimer levels and risk of recurrent venous thromboembolism | Q73864376 |
| | Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis | Q73919544 |
| | High plasma levels of factor VIII and the risk of recurrent venous thromboembolism | Q74197149 |
| | Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin | Q77199911 |
| | Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism | Q77499876 |
| | Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism | Q78670334 |
| | High-density lipoprotein and the risk of recurrent venous thromboembolism | Q79985834 |
| | Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial | Q79996095 |
| | Deep venous thrombosis: rate of spontaneous lysis and thrombus extension | Q80111570 |
| | Racial and gender differences in the incidence of recurrent venous thromboembolism | Q80213959 |
| | Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis | Q80557419 |
| | Recurrent venous thromboembolism in men and women | Q80961613 |
| | High risk of recurrent venous thromboembolism in men | Q81183986 |
| | Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study | Q81322442 |
| | Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism | Q81761509 |
| | Overweight, obesity, and the risk of recurrent venous thromboembolism | Q81769586 |
| | Recurrence rate after a first venous thrombosis in patients with familial thrombophilia | Q81885362 |
| | Family history for venous thromboembolism and the risk for recurrence | Q82345821 |
| | Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time | Q83193158 |
| | A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families | Q84155372 |
| | Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism | Q84401897 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | venous thromboembolism | Q9397786 |
| P304 | page(s) | S63-7 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | American Journal of Hematology | Q4744246 |
| P1476 | title | Predicting the risk of venous thromboembolism recurrence | |
| P478 | volume | 87 Suppl 1 | |